Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 835

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 6
Chunk 835
---
’s performance; develop, recommend to the Board and annually review a set of corporate governance principles applicable to the Company; and oversee any related matters required by the federal securities laws.

54

Item 11. EXECUTIVE COMPENSATION.

Executive Compensation

Our named executive officers for the year ended September 30, 2025 were Pardeep Nijhawan, MD, Director, Chief Executive Officer and Corporate Secretary; Peter Weiler, Chief Financial Officer; Michael Brooks, PhD, President; and Stephen Lemieux, CPA, former Chief Executive Officer.

Summary Compensation Table

The following table sets forth information regarding the compensation awarded to, earned by or paid to the named executive officers for the years ended September 30, 2025 and September 30, 2024

			Name and Principal Position

			Fiscal Year

			Salary ($)

			Bonus ($)

			Stock Awards ($) (1)

			All Other Compensation ($)

			Total ($)

			Pardeep Nijhawan, MD

			2025

			$
			357,696
			(2)
			 
			$
			93,717

			$
			522,931
			(3)
			 
			$
			32,415
			(4)
			 
			$
			1,006,759

			Director, Chief Executive Officer and Corporate Secretary

			2024

			357,696
			(5) 

			72,434

			-

			34,598
			(4) 

			464,728

			Michael Brooks, PhD

			2025

			335,340

			87,859

			411,671
			(6)

			27,007
			(7) 

			861,877

			President

			2024

			335,340

			67,906

			-

			25,741
			(7) 

			428,987

			Peter Weiler (8)

			2025

			125,000

			-

			129,143
			(9)

			10,558
			(10) 

			264,701

			Chief Financial Officer

			Stephen Lemieux, CPA (11)

			2025

			192